NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/09/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization977.18 mln
Float62.12 mln
Earnings Date07/30/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.7
Likely reliable
1-Year Forecast
18.62
Strong upside
Relative Strength
95
/ 100
Top performer
Debt / Equity
1.55
High leverage
ROE
-52.20
Deeply negative
Business Description
QuidelOrtho Corporation, headquartered in San Diego and founded in 1979, develops and sells a broad range of diagnostic tools used to detect disease, monitor patient health, and ensure the safety of blood transfusions. Its products span laboratory testing equipment, rapid point-of-care devices, blood screening systems, and molecular diagnostic platforms used to identify infectious diseases. The company serves hospitals, clinics, laboratories, pharmacies, and blood banks, among other settings, selling both through its own sales team and a network of distributors. QuidelOrtho operates across North America, Europe, the Middle East, Africa, Asia, and Latin America, with some products also available for personal, non-prescription use.
